Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis - Université de Lorraine Access content directly
Journal Articles New England Journal of Medicine Year : 2019

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Bruce Sands
  • Function : Author
William Sandborn
  • Function : Author
Remo Panaccione
  • Function : Author
Christopher O’brien
  • Function : Author
Hongyan Zhang
Jewel Johanns
  • Function : Author
Omoniyi Adedokun
  • Function : Author
Katherine Li
  • Function : Author
Gert van Assche
  • Function : Author
Stephan Targan
  • Function : Author
Maria Abreu
  • Function : Author
Tadakazu Hisamatsu
  • Function : Author
Philippe Szapary
  • Function : Author
Colleen Marano
  • Function : Author

Dates and versions

hal-03144504 , version 1 (17-02-2021)

Identifiers

Cite

Bruce Sands, William Sandborn, Remo Panaccione, Christopher O’brien, Hongyan Zhang, et al.. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine, 2019, 381 (13), pp.1201-1214. ⟨10.1056/NEJMoa1900750⟩. ⟨hal-03144504⟩
11 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More